VILMA BRAMASCO: Open Payments
NPI 1528787074 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $278 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
| Janssen Biotech, Inc. | 1 | $69 |
| Sumitomo Pharma America, Inc. | 1 | $62 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $14 |
Products named: XTANDI, INGREZZA, RYBREVANT, GEMTESA, BRIDION, PYLARIFY.
Industry payments across IA — which companies pay providers there.
